PHAGEPRO, INC.
Phages for a healthier world
PHAGEPRO, INC. was founded in 2019, is headquartered in MANSFIELD, United States, lists 1–10 employees, and has $4.3M in recorded funding across 3 rounds.
- Headquarters
- MANSFIELD, Massachusetts
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2G
- Website
- phageproinc.com
- Total Funding
- $4.3M
- Last Round
- $1.0M Venture RoundJan 2025
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.
About
PhagePro is an early-stage biotechnology company developing bacteriophage-based therapeutics to combat antibiotic resistance in the world's most vulnerable communities. Its lead program, ProphaLytic-Vc, targets cholera prevention using a shelf-stable, easy-to-administer phage therapeutic currently advancing toward first-in-human clinical studies.
Summary
PHAGEPRO, INC. is a Biotech company based in MANSFIELD, United States, founded in 2019. It lists 1–10 employees. It has raised $4.3M in total across 3 rounds, most recently a $1.0M Venture Round in Jan 2025. Investors include National Institutes of Health.
Funding History
2025 (est.)
Sign up to see all 3 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/phagepro-inc"><img src="https://indexed.vc/api/badge/company/phagepro-inc" alt="PHAGEPRO, INC. on Indexed.vc" width="260" height="76" /></a>